CClinicalTrials.gg
CompletedNCT00382785Updated Dec 21, 2010Results posted

Psychosocial Outcomes in Online Cancer Support Groups

An interventional study of moderated support and peer-led in Breast Cancer, sponsored by Christiana Care Health Services. Completed at 1 site in United States. Open to female participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2010-12-21.

Sponsored by Christiana Care Health Services · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
21 Years and older
Sex
Female
01

Study summary

Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. This objective will be addressed by the following specific aims:

  1. Specific Aim #1 is to determine if there is a difference in depressive symptoms between women with breast cancer assigned to one of two treatment conditions: moderated online support or peer-led online support.

    • H1: Women with breast cancer who participate in moderated online support will report fewer depressive symptoms than women with breast cancer in peer led online support.
  2. Specific Aim #2 is to determine if there is a difference in perceived social support between women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.

    • H2: Women with breast cancer who participate in moderated online support will report greater perceived social support than women with breast cancer in peer-led online support.
  3. Specific Aim #3 is to determine if there is a difference in quality of life in women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.

    • H3: Women with breast cancer who participate in moderated online support will report better quality of life than women with breast cancer in peer-led online support.

NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we decided to omit a "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.

Read the detailed description

Purpose/Specific Aims: The purpose of this randomized two-group longitudinal study is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. Rationale/Significance of study: No research has explored differences in psychosocial outcomes between online support groups that use a professional moderator and those that use a peer-led (self-help) format. This study will address one of the goals put forth in the 2003-2005 ONS Research Agenda, by studying the effects of technology based interventions (online support) on psychosocial outcomes (depression, perceived social support, quality of life) in women with breast cancer. This work will add to the nursing research base with regard to online support for women with breast cancer and provide a springboard for additional studies to enhance the research base. Conceptual Framework: The concept of openness, based on the mutual interaction between human beings and their environment, and emphasized in Rogers' Science of Unitary Human Beings provides a basis for this project. The research will utilize two different support environments and measure how interactions in each affect psychosocial outcomes over time. Main Research Variables: The independent variables are two treatment conditions (moderated online support, peer-led online support). The dependent variables are depressive symptoms, perceived social support, and quality of life. Design: A randomized longitudinal design, comparing two types of online support groups, on the basis of three principal measures, will be used. Each measure will be obtained at baseline and at three later timepoints. Setting: Support groups will be accessed from secure and password protected university web pages devoted exclusively to this study. Sample: Sixty women with breast cancer, at least 21 years of age, who have Internet access will be recruited. Methods: Women will be randomly assigned to one of the two treatment conditions (moderated online support, peer-led online support) given a password, and instructed to complete a Demographic Form and the study questionnaires online. All subjects will be asked to complete the study questionnaires again at 6, 12, and 16 weeks. Moderated groups will run in a semi-structured format over 12 weeks, with a different discussion topic moderated each week by the moderator. Peer-led groups will be run in a peer support format over 12 weeks. Implications for practice: Women with breast cancer are turning to online resources for support. Nurses should be aware of the benefits/limitations of this support alternative. A cost benefit may be suggested if it is shown that peer-led online support has psychosocial benefits similar to professionally facilitated groups. Additional research is needed to explore the impact of online support on psychosocial outcomes in people with other cancers, minorities, and men. This study will add important information to the research base regarding online support groups and help determine the best strategy for online cancer support.

NOTE: It was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we dropped the "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • online
  • support
  • breast cancer
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 51 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Christiana Care Health Services is the lead sponsor of 94 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Clinical diagnosis of breast cancer

  • Female
  • At least 21 years of age
  • Internet access; Able to read and write English
  • Have completed treatment for breast cancer in the past 36 months or are receiving treatment
  • Do not currently belong to an online or face-to-face cancer support group
  • Internet access

Exclusion Criteria:

  • Male
  • not diagnosed with breast cancer
  • under 21 years of age
  • received treatment more than 36 months ago for breast cancer
  • no Internet access
  • unable to read and write English
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    moderated online support

    12-week online support led by a healthcare professional

    Behavioral: moderated support

  • Experimental
    peer-led support

    12-week online support group in a peer-led format

    Behavioral: peer-led

Interventions

  • Behavioralmoderated support

    one 12-week online support group led by a professional healthcare provider

  • Behavioralpeer-led

    12-week online support in a peer-led format

06

What researchers measure

Primary outcomes

  1. Scores on the Personal Resource Questionnaire 85.

    The Personal Resource Questionnaire 85 (PRQ85), Part II measures perceived social support and consists of 25 items in a seven-point Likert format which are rated from seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicative of higher levels of perceived social support. Alpha reliability of the PRQ 85 has been demonstrated at \>.90

    Time frame: 16 weeks

  2. Scores on the CES-D Scale

    The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report scale widely used in the assessment of depression. Each item is given a rating of 0 to 3, with a potential range of 0 to 60 for the entire scale. Higher scores are associated with depression. The cutoff for the diagnosis of Major Depressive Disorder on the CES-D is 16. The instrument is a reliable measure (Alpha \>.85) of depression

    Time frame: 16 weeks

  3. Scores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).

    The Rotterdam Symptom Checklist (RSCL) measures quality of life in cancer patients. The RSCL checklist includes a QOL life question on a scale of 1 (excellent) to 7 (extremely poor). This was used as a measure of overall QOL.

    Time frame: 16 weeks

07

Results

Posted Dec 21, 2010
Limitations and caveats
One limitation was the lack of a control group of women who did not take part in an online or face-to-face support group. The reasons for this are explained above.

Participant flow

Subjects were recruited via flyers, word of mouth, at clinics, and via university electronic news. Participants were recruited from August 2005 through December 2008.

Participant flow — Overall Study
MilestoneModerated GroupNon-facilitated (Peer-led)
Started2526
Completed2526
Not completed00

Outcome measures

PrimaryScores on the Personal Resource Questionnaire 85.

The Personal Resource Questionnaire 85 (PRQ85), Part II measures perceived social support and consists of 25 items in a seven-point Likert format which are rated from seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicative of higher levels of perceived social support. Alpha reliability of the PRQ 85 has been demonstrated at \>.90

Time frame:
16 weeks
Reported as:
Mean · Scores on a scale
Scores on the Personal Resource Questionnaire 85.
Scores on a scaleModerated GroupNon-facilitated (Peer-led)
Scores on the Personal Resource Questionnaire 85.50.22 ± 3.2353.44 ± 3.08
Statistical analysis
  • Moderated Group vs Non-facilitated (Peer-led) · univariate analysis · p = .315
PrimaryScores on the CES-D Scale

The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report scale widely used in the assessment of depression. Each item is given a rating of 0 to 3, with a potential range of 0 to 60 for the entire scale. Higher scores are associated with depression. The cutoff for the diagnosis of Major Depressive Disorder on the CES-D is 16. The instrument is a reliable measure (Alpha \>.85) of depression

Time frame:
16 weeks
Reported as:
Mean · Scores on a scale
Scores on the CES-D Scale
Scores on a scaleModerated GroupNon-facilitated (Peer-led)
Scores on the CES-D Scale9.65 ± 1.9812.97 ± 1.84
Statistical analysis
  • Moderated Group vs Non-facilitated (Peer-led) · univariate analysis · p = .23Null Hypothesis: There will be no difference between the moderated and peer-led groups based on type of online support (moderated; peer-led)
PrimaryScores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).

The Rotterdam Symptom Checklist (RSCL) measures quality of life in cancer patients. The RSCL checklist includes a QOL life question on a scale of 1 (excellent) to 7 (extremely poor). This was used as a measure of overall QOL.

Time frame:
16 weeks
Reported as:
Mean · Scores on a scale
Scores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).
Scores on a scaleModerated GroupNon-facilitated (Peer-led)
Scores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).1.90 ± .312.30 ± .36
Statistical analysis
  • Moderated Group vs Non-facilitated (Peer-led) · Univariate Analysis · p = .32

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Moderated—0/25 (0%)0/25 (0%)
Peer-led—0/26 (0%)0/26 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Moderated GroupNon-facilitated (Peer-led)Total
<=18 years000
Between 18 and 65 years232548
>=65 years213
Age Continuous
Age Continuous(years)Moderated GroupNon-facilitated (Peer-led)Total
Mean52.97 ± 10.7551.52 ± 8.9252.25 ± 9.95
Sex: Female, Male
Sex: Female, Male(Participants)Moderated GroupNon-facilitated (Peer-led)Total
Female252651
Male000
Region of Enrollment
Region of Enrollment(participants)Moderated GroupNon-facilitated (Peer-led)Total
United States252651
08

Study locations

1 site
  • University of Delaware
    Newark, Delaware 19716, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 21, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00382785
Lead sponsor
Christiana Care Health Services
First posted
Oct 2, 2006
Start date
Sep 2006
Primary completion
Jul 2009
Completion
Jul 2009
Results posted
Dec 21, 2010
Last update
Dec 21, 2010

Study contacts

Paula Klemm, PhD
principal investigator · University of Delaware School of Nursing

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion